CARsgen Therapeutics Holdings Ltd.(HK:2171)
HK$9.30-0.46 (-4.71%)
HK:2171
CARsgen Therapeutics Holdings Ltd. financials statements
HK$9.30
At close:-0.46 (-4.71%)
Want to see HK:2171 full AI Analyst Report?
CARsgen Therapeutics Holdings Ltd. (2171) Income Statement
3 Followers
CARsgen Therapeutics Holdings Ltd. Income Statement
Last quarter (Q2 2026), CARsgen Therapeutics Holdings Ltd.'s total revenue was ¥61.92M, an increase of 876.64% from the same quarter last year. In Q2, CARsgen Therapeutics Holdings Ltd.'s net income was ¥-66.66M. See CARsgen Therapeutics Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 125.66M | ¥ 39.42M | ¥ 0.00 | ¥ 0.00 | ¥ 25.81M | |
| ¥ 79.95M | ¥ 14.75M | ¥ 0.00 | ¥ 0.00 | ¥ 25.81M | |
| ¥ 184.16M | ¥ 822.94M | ¥ 767.65M | ¥ 881.30M | ¥ 599.72M | |
| Depreciation and Amortization | ¥ 29.50M | ¥ 79.56M | ¥ 87.39M | ¥ 81.53M | ¥ 52.45M |
| ¥ -198.40M | ¥ -482.66M | ¥ -697.65M | ¥ -724.11M | ¥ -534.95M | |
| ¥ -104.21M | ¥ -808.19M | ¥ -767.65M | ¥ -881.30M | ¥ -573.90M | |
| ¥ 1.30M | ¥ 10.40M | ¥ 20.26M | ¥ -9.65M | ¥ -4.16B | |
| ¥ -102.91M | ¥ -797.79M | ¥ -747.39M | ¥ -890.95M | ¥ -4.74B | |
| ¥ -97.86M | ¥ -798.13M | ¥ -747.79M | ¥ -892.25M | ¥ -4.74B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.18 | ¥ -1.44 | ¥ -1.34 | ¥ -1.62 | ¥ -12.26 |
| Diluted EPS | ¥ -0.18 | ¥ -1.44 | ¥ -1.34 | ¥ -1.62 | ¥ -12.26 |
| Weighted Average Shares Outstanding | 552.06M | 552.88M | 556.13M | 551.63M | 549.89M |
| Weighted Average Shares Outstanding (Diluted) | 552.06M | 552.88M | 556.13M | 551.63M | 549.89M |
Currency in CNY

